Home
NAGE
NAGE News

Latest Niagen Bioscience Inc. Common Stock (NAGE) News on November 26, 2025

MT Newswires

12 days ago

Correction: Niagen Says Long COVID Trial Exploring Supplement Failed to Show 'Statistically Significant Differences' in Meeting Endpoints Versus Placebo Groups

Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)

Business Wire

13 days ago

Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)

Shareholders Can Be Confident That Niagen Bioscience's (NASDAQ:NAGE) Earnings Are High Quality

Simply Wall St.

13 days ago

Shareholders Can Be Confident That Niagen Bioscience's (NASDAQ:NAGE) Earnings Are High Quality

MT Newswires

13 days ago

Niagen Bioscience Says Supplement Failed to Meet Endpoints in Study of Long COVID-19 Patients

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

Business Wire

13 days ago

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

3 Growth Companies With High Insider Ownership And Up To 26% Revenue Growth

Simply Wall St.

14 days ago

3 Growth Companies With High Insider Ownership And Up To 26% Revenue Growth

Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Simply Wall St.

19 days ago

Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

MT Newswires

19 days ago

Niagen Bioscience Approves $10 Million Stock Buyback Program

Niagen Bioscience Announces $10 Million Share Repurchase Program

Business Wire

20 days ago

Niagen Bioscience Announces $10 Million Share Repurchase Program

Strong Q3 Results and Raised Guidance Might Change the Case for Investing in Niagen Bioscience (NAGE)

Simply Wall St.

20 days ago

Strong Q3 Results and Raised Guidance Might Change the Case for Investing in Niagen Bioscience (NAGE)

3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value

Simply Wall St.

20 days ago

3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value

3 Stocks Estimated To Be Up To 46.5% Below Intrinsic Value

Simply Wall St.

21 days ago

3 Stocks Estimated To Be Up To 46.5% Below Intrinsic Value

Niagen Bioscience Inc (NAGE) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com

21 days ago

Niagen Bioscience Inc (NAGE) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates

Zacks

21 days ago

Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates

Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline

Zacks

a month ago

Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline

Niagen Bioscience (NAGE) Reports Next Week: What to Expect

Zacks

a month ago

Niagen Bioscience (NAGE) Reports Next Week: What to Expect

3 Growth Companies With Insider Ownership Up To 29%

Simply Wall St.

a month ago

3 Growth Companies With Insider Ownership Up To 29%

Owning 37% shares,institutional owners seem interested in Niagen Bioscience, Inc. (NASDAQ:NAGE),

Simply Wall St.

2 months ago

Owning 37% shares,institutional owners seem interested in Niagen Bioscience, Inc. (NASDAQ:NAGE),

MT Newswires

2 months ago

Niagen Bioscience Raises Fiscal 2025 Net Sales Growth Outlook; Shares Up Pre-Bell

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

Business Wire

2 months ago

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

Business Wire

2 months ago

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

Three Growth Stocks With Strong Insider Commitment

Simply Wall St.

2 months ago

Three Growth Stocks With Strong Insider Commitment

Even though Niagen Bioscience (NASDAQ:NAGE) has lost US$55m market cap in last 7 days, shareholders are still up 623% over 3 years

Simply Wall St.

5 months ago

Even though Niagen Bioscience (NASDAQ:NAGE) has lost US$55m market cap in last 7 days, shareholders are still up 623% over 3 years

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Business Wire

5 months ago

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Niagen Bioscience to Participate in the BIO 2025 International Convention

Business Wire

5 months ago

Niagen Bioscience to Participate in the BIO 2025 International Convention

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Business Wire

6 months ago

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference

Business Wire

6 months ago

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference

3 Growth Companies With High Insider Ownership And Up To 18% Revenue Growth

Simply Wall St.

6 months ago

3 Growth Companies With High Insider Ownership And Up To 18% Revenue Growth

3 Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

6 months ago

3 Stocks That May Be Trading Below Their Estimated Value

Exploring May 2025's Undervalued Small Caps With Insider Action

Simply Wall St.

6 months ago

Exploring May 2025's Undervalued Small Caps With Insider Action

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

7 months ago

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

7 months ago

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Business Wire

7 months ago

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Business Wire

7 months ago

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Three High Growth Companies Insiders Are Eager To Hold

Simply Wall St.

7 months ago

Three High Growth Companies Insiders Are Eager To Hold

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Business Wire

7 months ago

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Business Wire

7 months ago

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders

Simply Wall St.

7 months ago

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Business Wire

8 months ago

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Growth Companies With High Insider Ownership For April 2025

Simply Wall St.

8 months ago

Growth Companies With High Insider Ownership For April 2025

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Simply Wall St.

8 months ago

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Why ChromaDex Corp (CDXC) Is Surging In 2025?

Insider Monkey

8 months ago

Why ChromaDex Corp (CDXC) Is Surging In 2025?

Share on Social Networks: